DailyMed: About DailyMed
REBETOL is Schering Corporation's brand name for ribavirin, a nucleoside analog. .... Ribavirin Cmin values were similar following administration of REBETOL ...
http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?id=6312...
|
Dose adjustments of PegIntron and Rebetol for certain patients ...
8 May 2009 ... Dose adjustments of PegIntron and Rebetol for certain patients with chronic hepatitis C.
http://www.fda.gov/ForConsumers/ByAudience/ForPatientAdvocat...
|
FDA Safety Changes: Keppra, Naropin, Rebetol
22 Dec 2006 ... The FDA has approved revisions to the safety labeling for levetiracetam tablets and oral solution (Keppra), ropivacaine HCl injection ...
http://www.medscape.com/viewarticle/549821...
|
PegIntron/REBETOL Combo Pack containing: PegIntron REDIPEN Single ...
12 Jul 2009 ... PegIntron/REBETOL Combo Pack containing: PegIntron REDIPEN Single-dose Delivery System (peginterferon alfa-2b) and REBETOL (ribavirin, ...
http://www.fda.gov/Safety/MedWatch/SafetyInformation/Safety-...
|
FDA Approvals: Lusedra and Pegintron/Rebetol
The FDA has approved fospropofol disodium injection (Lusedra) and a new indication for combination therapy with peginterferon alfa-2b and ribavirin ...
http://www.medscape.com/viewarticle/586248...
|
PegIntron and Rebetol (peginterferon alfa-2b and ribavirin)
19 Jun 2009 ... The most serious possible side effects of Peglntron and PegIntron/Rebetol therapy include: Body Organ Problems ...
http://www.fda.gov/Safety/MedWatch/SafetyInformation/Safety-...
|
International Approvals: DCVax-Brain, PegIntron/Rebetol, Revlimid
16 Jul 2007 ... Switzerland has approved a therapeutic vaccine (DCVax-Brain); the EU has improved an expanded indication for combination therapy with ...
http://www.medscape.com/viewarticle/559809...
|
103949s5171 Peginterferon (Rebetol) Statistical PREA
PeglntronTM in combination with Rebetol®, which is a FDA-approved treatment for ... combination with Rebetol® in previously untreated pediatric subjects, ...
http://www.fda.gov/downloads/Drugs/DevelopmentApprovalProces...
|
International Approvals: Remicade, Vasovist, Peg-Intron, Rebetol
10 Oct 2005 ... The EU has approved a new indication for infliximab injection (Remicade), gadofosveset trisodium injection (Vasovist), and a new indication ...
http://www.medscape.com/viewarticle/514283...
|
Largest Hepatitis C Trial in U.S. Patients Shows Weight-Based ...
These results from WIN-R (Weight-Based Dosing of PEG-INTRON and REBETOL), a community-based access trial involving more than 4900 patients at 225 centers
...
http://nyp.org/news/hospital/910.html...
|
